Ariad Sues Amgen, Wyeth Over Enbrel
Filed Friday in the U.S. District Court for the District of Delaware, the lawsuit accuses Amgen and Wyeth of trampling Ariad’s patent for cell-signaling technology, which was issued in 2002 and expires in 2019.
The lawsuit was filed one year after Amgen issued a preemptive strike against Ariad in the same court. While the...
To view the full article, register now.